Human health

RespiVir (COVID-19 /FluA /FluB)

Kit for simultaneous detection of Influenza A, Influenza B and SARS-CoV-2 viruses

RT-qPCR detection and differentiation of respiratory viruses Influenza A / Influenza B / SARS-CoV-2 for simultaneous diagnosis of influenza and Covid-19 Types of viruses identified: Influenza A: H1N1 and H3N2 lines Influenza B: Victoria and Yamagata lines SARS-CoV-2: type The complete kit includes: RT-qPCR master mix (including internal control : primers and probe specific to the human RNase P gene) A positive control (inactivated and quantified SARS-CoV-2, Influenza A and Influenza B viruses) A negative control (RNA from a qualified human cell line without the presence of Influenza A, Influenza B and SARS-CoV-2 viruses) The controls are used to validate the extraction, RT (Reverse transcriptase) and PCR steps Reliable, clear and precise results thanks to the included controls and the absence of background noise

Indication

In vitro diagnostic medical device, for professional use in laboratories staffed by qualified personnel

Principle

Real-time PCR

Withdrawal

Nasopharyngeal

Target sequences

M gene (FluA), NS gene (FluB), ORF1ab gene and N gene (SARS-CoV-2); endogenous control (RNase P)

Detection Limit (LoD)

SARS-CoV-2 = 100 copies/reaction; Influenza A and Influenza B = 1 TCID50/mL

Specific

SARS-CoV-2= 100%; Flu A and B= 100%.

Sensitivity

SARS-CoV-2= 100%; Flu A and B= 100%.

Storage (t°C)

-25°C/-15°C

Catalog number

KSC2FluAB

Packaging

96 tests

Manufacturer

Appolon Bioteck

Country

France

Ask for a quote

If you have any questions or would like to discuss our services, we invite you to contact us. Our team is always available to assist you, 7 days a week, and is committed to responding to all your requests in less than 24 hours.

Please enable JavaScript in your browser to complete this form.

Related products

Human health

Respi+ (FluA/ FluB/ COVID/ RSV)

Kit for the qualitative detection and simultaneous differentiation of influenza A, influenza B, SARS-CoV-2 and RSV RNA.

Read more

Human health

HybriSpot – Panel on tick-borne infections

Detection kit for major tick-borne pathogens

Read more

Human health

HybriSpot – Respiratory Panel

Detection kit for major pathogens causing acute respiratory infections

Read more

Any questions?

At RespiVir (COVID-19 /FluA /FluB), we understand the regulatory challenges faced by our French customers. We offer support in your accreditation process, including assistance in preparing the files needed to validate new techniques. Our approach is to provide local support, with flexibility and adaptability.

We are ISO 13485:2016 certified, demonstrating our commitment to the highest international standards for medical devices. What’s more, all our products are designed and manufactured in France, guaranteeing a high level of expertise and quality control.

We maintain a strategic buffer stock for all our distributed products, minimizing the risk of stock-outs. Should the need arise, our Lyon-based after-sales service is ready to react quickly to ensure your business continues uninterrupted.

Our logistics are optimized for rapid delivery throughout France and internationally. With efficient processes and a well-established distribution network, we ensure that your orders reach you in the shortest possible time.